Table 4.
Heart rate (HR; beats/min) and mean arterial pressure (MAP; mmHg) data during in vivo rat experiments of with BAY 60-6583.
| HR | MAP | HR | MAP | HR | MAP | HR | MAP | |
|---|---|---|---|---|---|---|---|---|
| Pre-Drug Baseline | 1′ Pre-Ischemia | 15′ Ischemia | 2h Reperfusion | |||||
| Vehicle | 358 ± 12 | 117 ± 6 | 362 ± 13 | 116 ± 6 | 372 ± 12 | 97 ± 7 | 350 ± 14 | 80 ± 10* |
| BAY 0.3 mg/kg | 350 ± 15 | 111 ± 4 | 367 ± 9 | 112 ± 4 | 383 ± 12 | 95 ± 10 | 343 ± 9 | 70 ± 8* |
| BAY 1.0 mg/kg | 384 ± 7 | 115 ± 7 | 378 ± 15 | 111 ± 6 | 388 ± 9 | 108 ± 8 | 352 ± 8 | 80 ± 7* |
| BAY 1 mg/kg +ATL 1 mg/kg | 385 ± 13 | 110 ± 3 | 383 ± 8 | 125 ± 4 | 365 ± 8 | 96 ± 7 | 350 ± 13 | 74 ± 3* |
P < 0.5 vs. respective pre-drug baseline value by repeated-measures ANOVA and Dunnett’s t test